Treatments

Case reports suggest electroconvulsive therapy is effective for treating catatonia in people with autism.

The latest study to show that autistic children tend to be overweight suggests that the risk is greatest for those at the severe end of the spectrum.

The first monkey with a mutation in SHANK3, a top autism gene, is nearly 3; it spends its days circling its cage rather than interacting with other monkeys.

Two studies published in the past two months provide new clues to when and how the cerebellum contributes to autism.

A team of researchers is trialing a fast approach to autism drug development: simultaneously testing candidates in people and in mice.

Administering a cholesterol drug alongside an antibiotic eases atypical behavior and restores the signaling balance in the brains of people with fragile X syndrome.

Modified stem cells show promise for delivering gene-based therapies to individuals with Angelman syndrome.

Applying sound waves to a mouse’s brain provides a safe way to push molecular probes into the brain to manipulate activity there.

The drug popularly known as ecstasy may boost sociability through brain circuits distinct from that underlying its ‘high.’